Download PDF
Dtsch Med Wochenschr 2018; 143(04): 287-291
DOI: 10.1055/s-0044-100353
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Fortschritte in der Kardiologie[*]

Vierzig Jahre – geprägt durch preußische TugendenAdvances in Cardiology40 Years Influenced by Erland Erdmann
Fikret Er
,
Michael Böhm
Further Information

Publication History

Publication Date:
22 February 2018 (online)

Also available at
    Permissions and Reprints

Prof. Dr. med. Erland Erdmann war seit jeher ein kritischer Geist. Er hat die kritische, wissenschaftliche Kardiologie genauso stark gefördert und fördert sie immer noch, wie er eine Verschreibung von homöopathischen Substanzen wie Anus bovis ablehnte. Mit transparenten preußischen Tugenden motivierte er seine Schüler, ihren Beitrag in der Patientenversorgung und Forschung zu leisten. Der folgende Artikel beleuchtet ausgewählte Gebiete der Kardiologie, die durch Erland Erdmann entscheidend mitentwickelt wurden.

Schlüsselwörter

Herzinsuffizienz - koronare Herzerkrankung - perkutane Intervention

Key words

congestive heart failure - coronary artery disease - percutaneous intervention

* Gewidmet Herrn Professor Dr. med. Erland Erdmann anlässlich seiner Verabschiedung als DMW-Herausgeber.


 

  • Literatur

  • 1 Baumgartner H, Falk V, Bax JJ. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Europ Heart j 2017; 38: 2739-2791
    CrossrefPubMedGoogle Scholar
  • 2 Bohm M, Beuckelmann D, Brown L. et al. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Europ Heart jJ 1988; 9: 844-852
    PubMedGoogle Scholar
  • 3 Bohm M, Gierschik P, Jakobs KH. et al. Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation 1990; 82: 1249-1265
    CrossrefPubMedGoogle Scholar
  • 4 Bohm M, Morano I, Pieske B. et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan innthe failing human myocardium. Circulation Res 1991; 68: 689-701
    CrossrefPubMedGoogle Scholar
  • 5 Bohm M, Pieske B, Ungerer M. et al. Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circulation research 1989; 65: 1201-1211
    CrossrefPubMedGoogle Scholar
  • 6 Desai AS, McMurray JJ, Packer M. et al. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Europ Heart J 2015; 36: 1990-1997
    CrossrefPubMedGoogle Scholar
  • 7 Erdmann E, Hofling B. [Percutaneous transfemoral valvuloplasty of calcified and non-calcified aortic valves]. Dtsch Med Wochenschr 1987; 112: 1067-1072
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Erdmann E, Krawietz W, Philipp G. et al. Purified cardiac cell membranes with high (Na+ + K+)ATPase activity contain significant NADH-vanadate reductase activity. Nature 1979; 282: 335-336
    CrossrefPubMedGoogle Scholar
  • 9 Erdmann E, Krawietz W, Phillipp G. et al. Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature 1979; 278: 459-461
    CrossrefPubMedGoogle Scholar
  • 10 Erdmann E, Schoner W. Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. 3. On the stability of the ouabain receptor against physical treatment, hydrolases and SH reagents. Biochim Biophy Acta 1973; 330: 316-324
    CrossrefPubMedGoogle Scholar
  • 11 Group CTS. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435
    CrossrefPubMedGoogle Scholar
  • 12 Hjalmarson A, Goldstein S, Fagerberg B. et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283: 1295-1302
    CrossrefPubMedGoogle Scholar
  • 13 McMurray JJ, Packer M, Desai AS. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. New Engl J Med 2014; 371: 993-1004
    CrossrefPubMedGoogle Scholar
  • 14 Pitt B, Zannad F, Remme WJ. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999; 341: 709-717
    CrossrefPubMedGoogle Scholar
  • 15 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Europ Heart J 2016; 37: 2129-2200
    CrossrefPubMedGoogle Scholar
  • 16 Roberts E, Ludman AJ, Dworzynski K. et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 2015; 350: h910
    CrossrefPubMedGoogle Scholar
  • 17 Schwinger RH, Bohm M, Koch A. et al. The failing human heart is unable to use the Frank-Starling mechanism. Circulation Res 1994; 74: 959-969
    CrossrefPubMedGoogle Scholar
  • 18 Schwinger RH, Bohm M, Muller-Ehmsen J. et al. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 1993; 88: 2267-2276
    CrossrefPubMedGoogle Scholar
  • 19 Swedberg K, Komajda M, Bohm M. et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376: 875-885
    CrossrefPubMedGoogle Scholar
  • 20 Ungerer M, Parruti G, Bohm M. et al. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circulation Res 1994; 74: 206-213
    CrossrefPubMedGoogle Scholar
  • 21 von Scheidt W, Bohm M, Schneider B. et al. Isolated presynaptic inotropic beta-adrenergic supersensitivity of the transplanted denervated human heart in vivo. Circulation 1992; 85: 1056-1063
    CrossrefPubMedGoogle Scholar